Rational Pharmacotherapy in Cardiology

Advanced search


Full Text:


The clinical case of a rare proarrhythmic effect of antiarrhythmic drugs with a poor prognosis (medication-induced atrial flutter in a patient with "malignant" Kent’s bundle) is presented. Radiofrequency ablation (RFA) is the most justified treatment method in patients with WPW-syndrome and "malignant" Kent’s bundle. RFA in descripted case has been postponed due to technical reasons. While waiting for RFA and after consideration of the potential risks and benefits the decision to use antiarrhythmic drugs to block the additional bundle was made. Paroxysm of broad-complex tachycardia developed on the third day of the treatment. It was regarded as a paroxysm of atrial fibrillation/flutter in the patient with WPW syndrome induced by taking antiarrhythmic drugs class 1C (allapinine). Review of the literature on the atrial fibrillation induced by antiarrhythmic of 1C class, and association of atrial fibrillation with WPW-syndrome is presented.

About the Authors

R. R. Mamatkazina
Institute of Clinical Cardiology named after A.L. Myasnikov , Russian Cardiology Research and Production Complex
Russian Federation

I. P. Kolos
State Research Center for Preventive Medicine
Russian Federation

S. E. Serdyuk
State Research Center for Preventive Medicine
Russian Federation

E. P. Mazygula
State Research Center for Preventive Medicine
Russian Federation

A. V. Sveshnikov
Russian National Medical and Surgical Center named after N.I. Pirogov
Russian Federation


1. Friedman P .L., Stevenson W.G. Proarrhythmia. Am J Cardiol 1998; 82:50N–8N.

2. Roden D.M. Mechanisms and management of proarrhythmia. Am J Cardiol 1998;82:49I–57I.

3. Chaudhry G.M., Haffajee C.I. Antiarrhythmic agents and proarrhythmia. Crit Care Med 2000;28:N158–64.

4. Falk R.H. Proarrhythmic responses to atrial antiarrhythmic therapy. In: Falk RH, Podrid PJ, eds. Atrial fibrillation: mechanisms and management. NY: Raven Press;1992:283–305.

5. el-Harari M.B., Adams P .C. Atrial flutter with 1:1 atrioventricular conduction caused by propafenone. Pacing Clin Electrophysiol 1998; 21:1999–2001.

6. van der Hooft C.S., Heeringa J., van Herpen G. et al. Drug-Induced Atrial Fibrillation. JACC 2004; 44; 11:2117-2024.

7. Nabar A., Rodriguez L.M., Timmermans C. et al. Class IC antiarrhythmic drug induced atrial flutter: electrocardiographic and electrophysiological findings and their importance for long term outcome after right atrial isthmus ablation. Heart 2001;85:424–429.

8. Sharma A.D., Klein G.J., Guiraudon G.M., Milstein S. Atrial fibrillation in patients with Wolff-Parkin- son-White syndrome: incidence after surgical ablation of the accessory pathway. Circulation 1985;1:161–9.

9. Haissaguerre M., Fischer B., Labbe T., Leme ´tayer P ., Monserrat P ., d’Ivernois C. et al. Frequency of recurrent atrial fibrillation after catheter ablation of overt accessory pathway. Am J Cardiol 1992;69:493–7.

10. Fujimura O., Klein G.J., Yee R., Sharma A.D. Mode of onset of atrial fibrillation in the Wolff-Parkin- son-White syndrome: how important is the accessory pathway? J Am Coll Cardiol 1990;15:1082–6.

11. Konoe A., Fukatani M., Tanigawa M., Isomoto S., Kadena M., Sakamoto T. et al. Electrophysiological abnormalities of the atrial muscle in patients with manifest Wolff-Parkinson-White syndrome associated with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 1992;15:1040–52.

12. Peinado R., Merino J.L., Gnatto M., Arias M.A. Atrial fibrillation triggered by postinfarction ventricular premature beats in a patient with Wolff-Parkinson-White syndrome. Europace 2005;7:221– 4.

13. Zhang Y ., Wang L. Atrial vulnerability is a major mechanism of paroxysmal atrial fibrillation in patients with Wolff-Parkinson-White syndrome. Med Hypotheses 2006;67:1345–7.

14. Hsieh M.H., Tai C.T., Chiang C.E., Tsai C.F ., Chen Y .J., Chan P . et al. Double atrial potentials recorded in the coronary sinus in patients with Wolff-Parkinson-White syndrome: a possible mechanism of induced atrial fibrillation. J Interv Card Electrophysiol 2004;11:97–103.

15. Kalarus Z., Kowalski O., Lenarczyk R., Prokopczuc J., Pasyk S. Electrophysiological features of orthodromic atrioventricular reentry tachycardia in patients with Wolff-Parkinson-White syndrome and atrial fibrillation. Pacing Clin Electrophysiol 2003;26:1479–88.

16. Soylu M., Demir A.D., Ozdemir O., Soylu O., Topaloglu S., Korkmaz S. et al. Increased P wave dispersion after the radiofrequency catheter ablation in overt preexcitation patients: the role of atrial vulnerability. Int J Cardiol 2004;95:167–70.

For citation:

Mamatkazina R.R., Kolos I.P., Serdyuk S.E., Mazygula E.P., Sveshnikov A.V. 1C-INDUCED ATRIAL FLUTTER IN A PATIENT WITH WPW SYNDROME: CASE REPORT AND REVIEW. Rational Pharmacotherapy in Cardiology. 2012;8(2):196-200. (In Russ.)

Views: 911

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)